Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 106,470 | 23,612 | 27,461 | 10,161 | 28,650 |
| Cost of Goods | 16,482 | 7,417 | 2,173 | 222 | 2,059 |
| Gross Profit | 89,988 | 16,195 | 25,288 | 9,939 | 26,591 |
| Operating Expenses | 153,413 | 103,615 | 75,065 | 52,726 | 18,921 |
| Operating Income | -62,943 | -87,003 | -49,604 | -42,565 | 7,729 |
| Interest Expense | 7,977 | 7,351 | 1,501 | 335 | 376 |
| Other Income | 157,598 | 4,214 | 5,056 | 16,095 | -15,874 |
| Pre-tax Income | 86,678 | -90,140 | -46,049 | -26,805 | -8,521 |
| Income Tax | 3,449 | 15,371 | N/A | -33 | 34 |
| Net Income Continuous | 83,229 | -105,511 | -46,049 | -26,772 | -8,555 |
| Net Income | $83,229 | $-105,511 | $-46,049 | $-26,772 | $-8,555 |
| EPS Basic Total Ops | 1.40 | -2.28 | -1.30 | -0.78 | -2.11 |
| EPS Basic Continuous Ops | 1.50 | -2.28 | -1.30 | -0.78 | -0.29 |
| EPS Diluted Total Ops | 1.35 | -2.28 | -1.30 | -0.78 | -2.11 |
| EPS Diluted Continuous Ops | 1.45 | -2.28 | -1.30 | -0.78 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -2.28 | -1.30 | -0.69 | -1.23 |
| EBITDA(a) | $-3,307 | $-81,504 | $-48,598 | $-41,621 | $8,136 |